Celltrion / A Korean Biosimilars Pioneer
Two decades ago, South Korean company Celltrion embarked on a quest to find the necessary resources to produce biopharmaceuticals. It took five years for their manufacturing plant to receive GMP…
The latest healthcare and pharma news from South Korea, including SK Bioscience’s COVID-19 vaccine, Daewoong’s partnership with AstraZeneca Korea and UCI Therapeutics, Vivozon production halt and GC's acquistion of US-based CDMO, BioCentriq. SK Bioscience’s COVID-19 vaccine to be tested against…
Two decades ago, South Korean company Celltrion embarked on a quest to find the necessary resources to produce biopharmaceuticals. It took five years for their manufacturing plant to receive GMP…
The 12th conference, Medical Korea 2022, to be held from March 10th to 11th, under the theme of “Global Healthcare, a New Leap Forward” with diverse programs including lectures of…
The 12th conference, Medical Korea 2022, to be held from March 10th to 11th, under the theme of “Global Healthcare, a New Leap Forward” with diverse programs including lectures of…
Eutilex’s CEO, Byoung S. Kwon, outlines the company’s approach to cancer research, including its antibodies and CAR-T-centred pipeline and focus on unmet needs. He also explains recent partnerships in China. … these different therapeutic platforms are based upon how we can handle these T-cells to attack cancer, and then how we can manage, modify or improve the cancer microenvironment.…
Founder and CEO of GeneMedicine, Dr Chae-Ok Yun, explains how the company, specialised in oncolytic virus development, has progressed since we last interviewed her two years ago, with one of…
Founder and CEO of GeneMedicine, Dr Chae-Ok Yun, explains how the company, specialised in oncolytic virus development, has progressed since we last interviewed her two years ago, with one of…
See our Cookie Privacy Policy Here